Beginning. Journey. Future.
Our Vision
Founders Rima Abdel-Massih, MD, and John Mellors, MD partnered to create Infectious Disease Connect to address the growing demand for ID expertise and expand its accessibility.
Since then, ID Connect has become a world leader in telemedical care of infectious diseases, antimicrobial stewardship, and infection control and prevention. At the heart of this success has been technological innovation, including the acquisition of ILÚM Health Solutions and its real-time decision support software. Our technology, precision medicine, and data science are paired with world-class ID physicians to effectively manage infectious diseases across the US.
At ID Connect, we strive to make people healthy, improve outcomes, and keep our communities free of infectious diseases.
Our Mission
To improve access and enable world-class specialized ID expertise to enrich lives and improve outcomes in a cost-effective manner with compassion, respect and integrity.
Meet Our Team
Who makes it all possible
Executive Team
-
Dave Zynn
President & Chief Executive Officer
Mr. Zynn is the President and CEO of ID Connect. He is a proven leader…
-
Rima Abdel-Massih, MD
Chief Medical Officer & Co-Founder
Dr. Abdel-Massih is the co-founder and Chief Medical Officer of ID Connect. She is an…
-
Riaan Erwee
Chief Operations Officer
As ID Connect’s Chief Financial Officer, Riaan is responsible for the financial and business operations…
-
Benjamin Curtis
Chief Technology Officer
As the CTO of ID Connect, Ben leads development and implementation, including strategic and feature…
-
Bridget Pascal
Chief Financial Officer
As ID Connect’s Chief Financial Officer, Bridget is responsible for the financial operations of the…
-
Mike Rinaldi
Vice President of Clinical Sales
Mike is the Vice President of Clinical Sales at ID Connect. Prior to ID Connect, he spent…
Dave Zynn
President & Chief Executive Officer
Mr. Zynn is the President and CEO of ID Connect. He is a proven leader with over 30 years of experience guiding healthcare services and telehealth companies through the growth stage to success. Dave brings organizational development, growth strategy and leadership to ID Connect.
Dave is also an advisor to his alma maters school of business, a member of a for-profit board of directors and is active with the Folds of Honor organization. He also enjoys sports, travel and is a longtime foodie.
Rima Abdel-Massih, MD
Chief Medical Officer & Co-Founder
Dr. Abdel-Massih is the co-founder and Chief Medical Officer of ID Connect. She is an expert in developing and instituting models of telemedicine services in Infectious Diseases (Tele-ID). She became the Director of Tele-ID Services at UPMC in 2016 and led its rapid growth regionally. The success of the Tele-ID program and the growing demand for access to ID specialists led Dr. Abdel-Massih and Dr. John Mellors, Chief of Infectious Diseases at UPMC to form ID Connect and extend academic level ID expertise to areas in need for ID specialists.
Dr. Abdel-Massih has been a faculty member at the University of Pittsburgh School of Medicine and UPMC since 2009. She joined the Division of Infectious Diseases at UPMC after completing her transplant infectious diseases fellowship training at the Mayo Clinic. She continues to serve as Director of Tele-ID Services at UPMC and as the Director of the Infectious Disease Fellowship Training Program. She is a member of the Infectious Diseases Society of America’s workgroup on Telehealth specialty.
Riaan Erwee
Chief Operations Officer
As ID Connect’s Chief Financial Officer, Riaan is responsible for the financial and business operations of the organization, as well as strategic business development activities.
Most recently, Riaan was one of the co-founders and Chief Operating Officer of ILÚM Health Solutions which was acquired by ID Connect in 2020. Riaan also spent over 21 years with Merck & Co., Inc. as Executive Director in Business Development, Strategy & Operations, which included managing the execution of strategic corporate initiatives from incubation to full scale operations as well as sourcing and closing multiple business development transactions. He served as a board member on invested entities and supported multiple exits and divestitures. Riaan started his career as an external auditor at EY.
Riaan is a Chartered Accountant (CA) and holds a Honors Bachelor of Accounting Science from the University of South Africa and a Bachelor of Commerce in Accountancy from the University of Pretoria. He was also a Certified Supply Chain Professional (CSCP) from the American Production and Inventory Control Society (APICS). He enjoys spending time outdoors and loves to cook over an open fire.
Benjamin Curtis
Chief Technology Officer
As the CTO of ID Connect, Ben leads development and implementation, including strategic and feature prioritization of our products.
Prior to joining ID Connect, Ben served as an executive team member for Syneos Health Managed Markets in charge of Integrated Strategic and Creative Services for hospital and market access initiatives with a focus on technology, operations, media, planning, and creative. During this time Ben acted as a client liaison for technical and strategic matters, and was hands-on in the creation, branding, and development of pharmaceutical services and the products themselves. Before joining Syneos Health, Ben worked with companies where he helped evolve a relationship marketing business into a more digital focused entity through both customer strategy and application development, and was involved in the design and development of one of the first online payroll applications.
In addition, Ben kicked off his technology career as one of three individuals launching, building, and managing an Internet Service Provider leading to the company’s acquisition.
Bridget Pascal
Chief Financial Officer
As ID Connect’s Chief Financial Officer, Bridget is responsible for the financial operations of the organization. Bridget has built finance teams from the ground up over the past twenty years of her career. She brings a vast knowledge of system implementations to streamline processes in finance and other areas of the company.
Bridget is a graduate of Virginia Tech, enjoys cheering on the Hokies and spending time with her three children and husband.
Mike Rinaldi
Vice President of Clinical Sales
Mike is the Vice President of Clinical Sales at ID Connect. Prior to ID Connect, he spent seven years with Melinta Therapeutics and The Medicines Company from 2014 through 2021 and served as the infectious disease medical science liaison for the Eastern Great Lakes region. Mike was an infectious disease/antibiotic stewardship pharmacist and clinical pharmacy manager at Waterbury Hospital in Connecticut from 2010 to 2014 and was the clinical pharmacy specialist in surgery at Norwalk Hospital in Connecticut from 2007 through 2010; he served on the Infection Control and Pharmacy and Therapeutics committees at both hospitals. He graduated from the University of Connecticut School of Pharmacy in 2005 with his PharmD, and then went on to complete an infectious diseases pharmacotherapy fellowship from 2005 through 2007 at the University of Connecticut Health Center.
Mike currently resides in Connecticut with his wife, Gwendolyn. They have two boys, Sebastiano and Alessandro, and a dog, Chloe. He enjoys working in his garden and doing yard work. Outside of the home, he likes to travel to different cities in the US and to Puerto Rico. In his spare time, Mike enjoys playing and watching sports as well as working out.
-
Alex Trzebucki, MD
Infectious Diseases Specialist, Clinical Assistant Professor of Medicine, UPMC
-
Andrew Huseman
Director of Integration
-
Angelia Parish
Senior Software Developer
-
Belma Ford
Senior Data Integration Expert
-
Benjamin Curtis
Chief Technology Officer
-
Brandon Smith, MD, PharmD
Infectious Diseases Specialist, Clinical Assistant Professor of Medicine, University of Pittsburgh School of Medicine; Division of Infectious Diseases, UPMC
Alex Trzebucki, MD
Infectious Diseases Specialist, Clinical Assistant Professor of Medicine, UPMC
Dr.Trzebucki’s interests include general infectious diseases, designing and operationalizing antimicrobial stewardship models, and developing ID technology solution in antimicrobial stewardship. He has particular interest in the development and implementation of next generation rapid molecular diagnostic modalities in Infectious Disease to address accurate, timely diagnosis and appropriate anti-microbial utilization.
Andrew Huseman
Director of Integration
Proactive leader with over 17 years of experience in the federal healthcare space, and expertise in emerging healthcare technologies, Andrew provides transformational leadership, develops strategic roadmaps, and develops effective solutions that ensure attainment of stakeholder objectives.
Andrew received his Bachelors in Computer Science from the University of Missouri, Kansas City. In his spare time, he enjoys spending time with his family, running, yard work, and any project that allows him to use problem solving skills.
Angelia Parish
Senior Software Developer
Angelia is a Senior Backend Developer at Infectious Disease Connect, Inc. She is relatively new to healthcare data, coming from the energy industry in Houston, Texas. Angelia is an avid nineteenth century flute enthusiast and can be seen most evenings running the neighborhoods with her dog.
Belma Ford
Senior Data Integration Expert
Belma started her career as a Microbiology Technologist in a busy urban hospital. Later she leveraged that knowledge to move into the healthcare informatics field. Her career reflects a passion for big data analysis, data quality, and optimizing reporting systems by supporting and innovating technology that aids users and improves existing processes. Belma has over 15 years of experience in SQL, data warehouses, data analysis, data management, support, application development and process improvement.
Benjamin Curtis
Chief Technology Officer
As the CTO of ID Connect, Ben leads development and implementation, including strategic and feature prioritization of our products.
Prior to joining ID Connect, Ben served as an executive team member for Syneos Health Managed Markets in charge of Integrated Strategic and Creative Services for hospital and market access initiatives with a focus on technology, operations, media, planning, and creative. During this time Ben acted as a client liaison for technical and strategic matters, and was hands-on in the creation, branding, and development of pharmaceutical services and the products themselves. Before joining Syneos Health, Ben worked with companies where he helped evolve a relationship marketing business into a more digital focused entity through both customer strategy and application development, and was involved in the design and development of one of the first online payroll applications.
In addition, Ben kicked off his technology career as one of three individuals launching, building, and managing an Internet Service Provider leading to the company’s acquisition.
Brandon Smith, MD, PharmD
Infectious Diseases Specialist, Clinical Assistant Professor of Medicine, University of Pittsburgh School of Medicine; Division of Infectious Diseases, UPMC
Dr. Brandon J. Smith is a Clinical Assistant Professor of Medicine at the University of Pittsburgh School of Medicine. He completed his pharmacy training at Duquesne University in Pittsburgh, PA (2012) obtaining his PharmD and a Concentration in Pediatrics. Dr. Smith went on to complete his medical training at the Marshall University in Huntington, WV (2016). He returned to Pittsburgh to complete his Internal Medicine Residency training at UPMC Mercy (2019) where he served as the Resident Chair of the Antimicrobial Stewardship Committee and stayed at UPMC to complete his Infectious Diseases Fellowship (2021). During his fellowship, Dr. Smith served as the Chief Infectious Diseases Fellow (2020-2021) and completed the Antimicrobial Stewardship Certification track. He has also obtained the Advanced Antimicrobial Stewardship Certification through MAD-ID (2018). Dr. Smith’s clinical interests include antimicrobial stewardship and de-labeling B-lactam allergies. His research interests include B-lactam therapeutic drug monitoring, B-lactam neurotoxicity and multi-drug resistant gram-negative infections.
Our Partners
Strengthened by
Our Partners
Strengthened by
Our Investors
Supported by
Our Investors
Supported by
